G Bruchelt
Overview
Explore the profile of G Bruchelt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
81
Citations
358
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bruchelt G, Klingebiel T, Treuner J, Beck J, Lode H, Seitz G, et al.
Int J Oncol
. 2011 May;
6(3):705-12.
PMID: 21556593
[I-131]mIBG, meta-iodobenzylguanidine, a catecholamine analogous compound, was synthesized by Wieland et al in 1979. It has been used for scintigraphic imaging of normal sympathetic tissue, of pheochromocytoma, and since 1983/84...
2.
Kuci S, Kuci Z, Schmid S, Seitz G, Muller I, Dufke A, et al.
Cell Prolif
. 2008 Jan;
41(1):12-27.
PMID: 18211283
Objectives: To generate non-haematopoietic tissues from mobilized haematopoietic CD133(+) stem cells. Materials And Methods: Mobilized peripheral blood CD133(+) cells from adult healthy donors were used. In vitro ability of highly...
3.
Harzer K, Rolfs A, Bauer P, Zschiesche M, Mengel E, Backes J, et al.
Neuropediatrics
. 2003 Dec;
34(6):301-6.
PMID: 14681755
This study describes a diagnostic pitfall in the laboratory diagnosis of patients with sphingomyelinase deficiency (SMD; Niemann-Pick disease types A and B; NPA and NPB), in cases where sphingomyelinase activity...
4.
Gerber C, Bruchelt G, Falk U, Kimpfler A, Hauschild O, Kuci S, et al.
Blood
. 2001 Nov;
98(10):3097-105.
PMID: 11698296
Chronic granulomatous disease (CGD) is an inherited primary immunodeficiency characterized by phagocytes devoid of a functioning nicotinamide adenine dinucleotide phosphate (NADPH) oxidase. The failure of CGD phagocytes to produce reactive...
5.
Renner S, Prohaska V, Gerber C, Niethammer D, Bruchelt G
J Chromatogr A
. 2001 May;
916(1-2):247-53.
PMID: 11382297
The aim of this study was to establish an isotachophoretic (ITP) method for the determination of the main compounds of glycolysis in human erythrocytes in order to analyze the influence...
6.
Renner S, Krumpelmann S, Bruchelt G, Wiesinger H, Niethammer D, Klingebiel T
Anticancer Res
. 2001 Feb;
20(6B):4531-8.
PMID: 11205300
Amifostine (Ethyol, WR-2721) has been clinically used in combination with high dose therapy of neuroblastoma stage 4 with melphalan, carboplatin and VP-16 in 14 patients. The amifostine group was compared...
7.
Seitz G, Bruchelt G, Kuci Z, Roginsky V, Wolburg H, Stegmann H, et al.
Med Pediatr Oncol
. 2000 Dec;
35(6):612-5.
PMID: 11107129
Background: 6-Hydroxydopamine (6-OHDA) was used for ex vivo purging of bone marrow from neuroblastoma cells before autologous transplantation. However, this concept failed because of the rapid autoxidation of 6-OHDA, which...
8.
Renner S, Kuci Z, dCruze H, Niethammer D, Bruchelt G
Electrophoresis
. 2000 Sep;
21(14):2828-33.
PMID: 11001289
The antifolate methotrexate (MTX) is widely used in cancer chemotherapy. In this study, we show that MTX (MTX-Glu1) and MTX-polyglutamates (MTX-Glu2-5) strongly inhibited the growth of the leukemic cell line...
9.
Seitz G, Stegmann H, Jager H, Schlude H, Wolburg H, Roginsky V, et al.
J Neurochem
. 2000 Jul;
75(2):511-20.
PMID: 10899926
6-Hydroxydopamine (6-OHDA) has been used for lesioning catecholaminergic neurons and attempted purging of neuroblastoma cells from hematopoietic stem cells in autologous bone marrow transplantation (ABMT). Neurotoxicity is mediated primarily by...
10.
Marini P, MacLEOD R, Treuner C, Bruchelt G, Bohm W, Wolburg H, et al.
Cancer Genet Cytogenet
. 2000 Feb;
112(2):161-4.
PMID: 10686945
We describe the establishment and characterization of a new neuroblastoma (Nb) cell line, SiMa, carrying the major recurrent chromosome changes associated with poor prognosis Nb, including amplification of N-MYC by...